Operating Segments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Segment reporting
Revenues	$ 186,198	$ 608,811	$ 548,615	$ 2,038,653
Loss from operations	(3,375,382)	(1,812,777)	(8,618,634)	(13,100,438)
Amortization and depreciation	8,875	17,187	26,614	52,635
Other income, net	(212,169)	22,617	(93,205)	115,288
Share-based compensation	79,721	66,572	255,147	211,266
Identifiable Assets	29,717,798		29,717,798		$ 19,891,235
Public Health Solutions
Segment reporting
Revenues	186,198	544,466	548,615	1,921,284
Loss from operations	(303,488)	(6,369)	(666,223)	(215,608)
Amortization and depreciation	314	6,651	941	21,272
Share-based compensation	6,518	8,377	20,002	26,219
Identifiable Assets	48,885		48,885		176,447
Specialized BioTherapeutics
Segment reporting
Revenues		64,345		117,369
Loss from operations	(1,799,898)	(643,793)	(4,632,872)	(9,810,296)
Amortization and depreciation	1,883	3,201	5,644	9,438
Other income, net	(26,123)	22,131	99,512	90,838
Share-based compensation	28,506	18,962	86,816	63,213
Identifiable Assets	72,483		72,483		147,784
Corporate
Segment reporting
Loss from operations	(1,271,996)	(1,162,615)	(3,319,539)	(3,074,534)
Amortization and depreciation	6,678	7,335	20,029	21,925
Other income, net	(186,046)	486	(192,717)	24,450
Share-based compensation	44,697	$ 39,233	148,329	$ 121,834
Identifiable Assets	$ 29,596,430		$ 29,596,430		$ 19,567,004